scholarly journals Does breast carcinoma belong to the Lynch syndrome tumor spectrum? – Somatic mutational profiles vs. ovarian and colorectal carcinomas

Oncotarget ◽  
2020 ◽  
Vol 11 (14) ◽  
pp. 1244-1256 ◽  
Author(s):  
Noora K. Porkka ◽  
Alisa Olkinuora ◽  
Teijo Kuopio ◽  
Maarit Ahtiainen ◽  
Samuli Eldfors ◽  
...  
2010 ◽  
Vol 8 (Suppl 1) ◽  
pp. P17
Author(s):  
Renee L Perrier ◽  
Paulein Van Galen ◽  
Janice L Pasieka ◽  
Tony Magliocco ◽  
A Innes

2012 ◽  
Author(s):  
Johanna E. Lotsari ◽  
Annette Gylling ◽  
Wael M. Abdel-Rahman ◽  
Marjukka Friman ◽  
Markku Aarnio ◽  
...  

2005 ◽  
Vol 4 (3) ◽  
pp. 245-248 ◽  
Author(s):  
Patrice Watson ◽  
Bronson Riley

2016 ◽  
Vol 469 (2) ◽  
pp. 135-144 ◽  
Author(s):  
Florence Boissière-Michot ◽  
Hélène Frugier ◽  
Alexandre Ho-Pun-Cheung ◽  
Evelyne Lopez-Crapez ◽  
Jacqueline Duffour ◽  
...  

2018 ◽  
Vol 142 (4) ◽  
pp. 523-528 ◽  
Author(s):  
Lindsay Alpert ◽  
Reetesh K. Pai ◽  
Amitabh Srivastava ◽  
Wendy McKinnon ◽  
Rebecca Wilcox ◽  
...  

Context.— Isolated loss of PMS2 staining is an uncommon immunophenotype in colorectal carcinomas, accounting for approximately 4% of tumors with microsatellite instability. Limited information regarding these tumors is available in the literature. Objective.— To compare the clinicopathologic features of colorectal carcinomas with isolated PMS2 loss by immunohistochemistry to those with other forms of mismatch repair deficiency. Design.— Ninety-three colorectal carcinomas with isolated PMS2 loss by immunohistochemistry and 193 with other forms of mismatch repair deficiency were identified. Forty (43%) of the isolated PMS2 loss cases and 35 control cases (18%) had a known germline mutation or a clinical diagnosis of Lynch syndrome. Results.— Overall, isolated PMS2-loss tumors occurred in significantly younger patients (P < .001) and in fewer female patients (P = .006). These tumors were significantly less likely to be right-sided (P = .001), high-grade (P = .01), or display histologic features of microsatellite instability (P < .001). The isolated PMS2-loss group also exhibited increased odds of disease-specific death (odds ratio [OR], 3.09; 95% CI, 1.41–6.85; P = .007). When the analysis was restricted to germline mutation/Lynch syndrome cases and controls, no significant differences were detected for age, sex, tumor location, tumor grade, histologic features, or distant metastases, although a trend toward increased odds of disease-specific death in the isolated PMS2-loss group was evident (OR, 3.87; 95% CI, 0.89–27.04; P = .10). Conclusions.— Unusual clinicopathologic features observed in colorectal carcinomas with isolated PMS2 loss are likely related to the high proportion of cases caused by germline mutations. Isolated PMS2-loss tumors may demonstrate more aggressive behavior than other tumors with microsatellite instability, but larger studies are needed to investigate that possibility further.


2016 ◽  
Author(s):  
Christina Therkildsen ◽  
Steen Ladelund ◽  
Lars Joachim Lindberg ◽  
Lars Smith-Hansen ◽  
Mef Nilbert

2012 ◽  
Vol 14 (3) ◽  
Author(s):  
Johanna E Lotsari ◽  
Annette Gylling ◽  
Wael M Abdel-Rahman ◽  
Taina T Nieminen ◽  
Kristiina Aittomäki ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document